A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases - PubMed (original) (raw)

• PMID: 8612600
• PMCID: PMC450088

Published Erratum

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

V Joukov et al. EMBO J. 1996.

No abstract available

PubMed Disclaimer

Erratum for

• A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
  Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. Joukov V, et al. EMBO J. 1996 Jan 15;15(2):290-98. EMBO J. 1996. PMID: 8617204 Free PMC article.

Similar articles

• A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
  Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. Joukov V, et al. EMBO J. 1996 Jan 15;15(2):290-98. EMBO J. 1996. PMID: 8617204 Free PMC article.
• A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
  Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C. Meyer M, et al. EMBO J. 1999 Jan 15;18(2):363-74. doi: 10.1093/emboj/18.2.363. EMBO J. 1999. PMID: 9889193 Free PMC article.
• Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
  Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME. Gilbert RE, et al. Lab Invest. 1998 Aug;78(8):1017-27. Lab Invest. 1998. PMID: 9714188
• Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
  Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD. Ozaki NK, et al. Invest Ophthalmol Vis Sci. 2002 May;43(5):1546-57. Invest Ophthalmol Vis Sci. 2002. PMID: 11980873

Cited by

• The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease.
  Simeroth S, Yu P. Simeroth S, et al. Front Cardiovasc Med. 2024 May 9;11:1392816. doi: 10.3389/fcvm.2024.1392816. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38798921 Free PMC article. Review.
• Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner.
  Liang J, Lei P, Su X, Gao J, Ren B, Zhang Y, Ma X, Ma W. Liang J, et al. Curr Cancer Drug Targets. 2024;24(11):1157-1168. doi: 10.2174/0115680096282997240101192452. Curr Cancer Drug Targets. 2024. PMID: 38321898
• Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.
  Hu Z, Zhao X, Wu Z, Qu B, Yuan M, Xing Y, Song Y, Wang Z. Hu Z, et al. Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x. Signal Transduct Target Ther. 2024. PMID: 38172098 Free PMC article. Review.
• Biology and therapeutic targeting of vascular endothelial growth factor A.
  Pérez-Gutiérrez L, Ferrara N. Pérez-Gutiérrez L, et al. Nat Rev Mol Cell Biol. 2023 Nov;24(11):816-834. doi: 10.1038/s41580-023-00631-w. Epub 2023 Jul 25. Nat Rev Mol Cell Biol. 2023. PMID: 37491579 Review.
• Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy.
  Huang X, Zhang L, Fu Y, Zhang M, Yang Q, Peng J. Huang X, et al. Front Bioeng Biotechnol. 2023 May 23;11:1199922. doi: 10.3389/fbioe.2023.1199922. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37288355 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal